Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
An epidemiological registry study to evaluate clinical practice treatment in patients with Bipolar Disorder treated with quetiapine XR and/or quetiapine IR
Age
Any age
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with a diagnosis of BD.
You may not be if
Patients with a diagnosis of any schizophrenia spectrum disorder after the diagnosis of bipolar disorder.
Clareo Health | An Epidemiological Registry Study to Evaluate Clinical Practice Treatment in Patients With Bipolar Disorder
